Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Jubilant Stock Holding Pvt Ltd has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE Intimation of Schedule of the Non Deal Road Show on March 16 and 17, 2016
Jubilant Life Sciences Ltd has informed BSE regarding "Intimation of Schedule of the Non Deal Road Show on March 16 and 17, 2016". Intimation of Schedule of the Non Deal Road Show on February 25 and 26, 2016
Jubilant Life Sciences Ltd has informed BSE regarding "Intimation of Schedule of the Non Deal Road Show on February 25 and 26, 2016". Exercise of ESOP Options
Jubilant Life Sciences Ltd has informed BSE that 550 options under Jubilant Employees Stock Option Plan 2005 (Plan 2005") and 54,789 options under JLL Employees Stock Option Plan 2011 (Plan 2011) have been exercised by the option holders.Pursuant to the terms of Plan 2005 and Plan 2011, the Nomination, Remuneration and Compensation Committee of the Company (the Committee) has approved transfer of 57,539 equity shares of Re. 1 each of... Jubilant Life Sciences clocks 117 cr profit
Jubilant Life Sciences has reported a net profit of 116.93 crore for the third quarter ended December 31, 2015. For the same quarter of the previous fiscal, the pharmaceutical major had posted a net ... Announces Q3 Results (Standalone & Consolidated), Limited Review Report (Standalone & Consolidated), Results Press Release & Presentation for the Quarter ended December 31, 2015
Jubilant Life Sciences Ltd has announced the following results for the quarter ended December 31, 2015:The Unaudited Standalone results for the Quarter ended December 31, 2015The Company has posted a net profit of Rs. 282.30 million for the quarter ended December 31, 2015 where as the same was net loss at Rs. (84.80) million for the quarter ended December 31, 2014. Total Income is Rs. 6531.20 million for the quarter ended December... Ministry of Commerce (MOFCOM) China has reduced the Anti-Dumping Duty on Pyridine from Jubilant to 17.6%
Jubilant Life Sciences Ltd has informed BSE regarding a Press Release dated February 06, 2016 titled "Ministry of Commerce (MOFCOM) China has reduced the Anti-Dumping Duty on Pyridine from Jubilant to 17.6%". Shareholding for the Period Ended December 31, 2015
Jubilant Life Sciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2015. For more details, kindly Click here Schedule of Investor Conference Call
Jubilant Life Sciences Ltd has informed BSE regarding "Schedule of Investor Conference Call". Q3 results on Feb 09, 2016
Jubilant Life Sciences Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 9, 2016, inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter ended December 31, 2015 (Q3).Further, as per the Companys Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the securities of the Company would remain closed for the Designated...